4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Astena Holdings Co., Ltd. (8095) operates in the Conglomerates industry and is headquartered in Chuo, Japan with about 1,543 employees. Its market capitalization is roughly JPY 22 billion. In the fiscal year ended 2025-11-30, 8095 reported JPY 62.7B in revenue and JPY 2.2B in net income.
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. It operates through four segments: Fine Chemicals, Health & Beauty Care, Medical, Industrial Chemicals Segment, and Social Impact Business Segment.
Interactive charts & full statements → Open the 8095 valuation workbench →
| Income statement | 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 | 2021-11-30 |
|---|---|---|---|---|---|
| Total Revenue | JPY 62.7B | JPY 58.0B | JPY 52.0B | JPY 49.6B | — |
| Gross Profit | JPY 21.9B | JPY 19.4B | JPY 16.3B | JPY 15.4B | — |
| Operating Income (EBIT) | JPY 3.0B | JPY 2.8B | JPY 1.1B | JPY 820M | — |
| Net Income | JPY 2.2B | (JPY 2.5B) | JPY 1.2B | JPY 580M | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 | 2021-11-30 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 735M) | (JPY 727M) | (JPY 719M) | (JPY 729M) | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 | 2021-11-30 |
|---|---|---|---|---|---|
| Total Assets | JPY 75.4B | JPY 64.6B | JPY 67.3B | JPY 63.6B | — |
| Total Liabilities | JPY 48.0B | JPY 39.3B | JPY 38.7B | JPY 36.5B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 8095 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms